Signalling pathways identified in salivary glands from primary Sjögren’s syndrome patients reveal enhanced adipose tissue development

References

• Jonsson R, Bolstad AI, Brokstad KA, et al. Sjogren’s syndrome – a plethora of clinical and immunological phenotypes with a complex genetic background. Ann NY Acad Sci. 2007;1108:433–447.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Vogelsang P, Volchenkov R, et al. The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141:1–9.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, et al. Topical and systemic medications for the treatment of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2012;8:399–411.
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Skarstein K, Jonsson R, et al. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol. 2007;34:2044–2049.
   PubMed Web of Science ®Google Scholar
• Hamel KM, Liarski VM, Clark MR. Germinal center B-cells. Autoimmunity. 2012;45:333–347.
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren’s syndrome. Arthritis Rheum. 2003;48:3187–3201.
   PubMed Web of Science ®Google Scholar
• Jung J, Choe J, Li L, et al. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur J Immunol. 2000;30:2437–2443.
   PubMed Web of Science ®Google Scholar
• Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren’s syndrome. Ann Rheum Dis. 2011;70:1363–1368.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Alex P, Jonsson MV, et al. Distinct profiles of Sjogren’s syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol. 2005;117:168–176.
   PubMed Web of Science ®Google Scholar
• Reksten TR, Jonsson MV, Szyszko EA, et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren’s syndrome. Rheumatology (Oxford). 2009;48:1102–1106.
   PubMed Web of Science ®Google Scholar
• Le Pottier L, Devauchelle V, Fautrel A, et al. Ectopic germinal centers are rare in Sjogren’s syndrome salivary glands and do not exclude autoreactive B cells. J Immunol. 2009;182:3540–3547.
   PubMed Web of Science ®Google Scholar
• Reksten TR, Johnsen SJ, Jonsson MV, et al. Genetic associations to germinal centre formation in primary Sjogren’s syndrome. Ann Rheum Dis. 2014;73:1253–1258.
   PubMed Web of Science ®Google Scholar
• Risselada AP, Kruize AA, Goldschmeding R, et al. The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren’s syndrome. Ann Rheum Dis. 2014;73:1537–1540.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Li L, Boumba D, et al. Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren’s syndrome. Clin Exp Rheumatol. 1998;16:63–65.
   PubMed Web of Science ®Google Scholar
• Skarstein K, Aqrawi LA, Oijordsbakken G, et al. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs. Autoimmunity. 2016;49:338–346.
   PubMed Web of Science ®Google Scholar
• Hjelmervik TO, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren’s syndrome patients from healthy control subjects. Arthritis Rheum. 2005;52:1534–1544.
   PubMed Web of Science ®Google Scholar
• Ramos HL, Valencia-Pacheco G, Alcocer-Varela J. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjogren’s syndrome. Scand J Rheumatol. 2008;37:35–39.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A. 2006;103:2770–2775.
   PubMed Web of Science ®Google Scholar
• Benchabane S, Boudjelida A, Toumi R, et al. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjogren’s syndrome. Int J Immunopathol Pharmacol. 2016;29:386–397.
   PubMed Web of Science ®Google Scholar
• Llorente L, Richaud-Patin Y, Fior R, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994;37:1647–1655.
   PubMed Web of Science ®Google Scholar
• Halse A, Tengner P, Wahren-Herlenius M, et al. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjogren’s syndrome. Scand J Immunol. 1999;49:533–538.
   PubMed Web of Science ®Google Scholar
• Vazquez-Villamar M, Palafox-Sanchez CA, Munoz-Valle JF, et al. Analysis of IL10 haplotypes in primary Sjogren’s syndrome patients from Western Mexico: Relationship with mRNA expression, IL-10 soluble levels, and autoantibodies. Human Immunol. 2015;76:473–479.
   PubMed Web of Science ®Google Scholar
• Villarreal GM, Alcocer-Varela J, Llorente L. Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjogren’s syndrome. Immunol Lett. 1996;49:105–109.
   PubMed Web of Science ®Google Scholar
• Ambrosi A, Espinosa A, Wahren-Herlenius M. IL-17: a new actor in IFN-driven systemic autoimmune diseases. Eur J Immunol. 2012;42:2274–2284.
   PubMed Web of Science ®Google Scholar
• Lisi S, Sisto M, D'Amore M, et al. Emerging avenues linking inflammation, angiogenesis and Sjögren's syndrome. Cytokine. 2013;61:693–703.
   PubMed Web of Science ®Google Scholar
• Sisto M, Lorusso L, Lisi S. TLR2 signals via NF-kappaB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjogren’s syndrome. Clin Exp Med. 2017;17:341–350.
   PubMed Web of Science ®Google Scholar
• Leehan KM, Pezant NP, Rasmussen A, et al. Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjogren’s syndrome. Autoimmunity. 2017;50:451–457.
   PubMed Web of Science ®Google Scholar
• Katsiougiannis S, Kapsogeorgou EK, Manoussakis MN, et al. Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Arthritis Rheum. 2006;54:2295–2299.
   PubMed Web of Science ®Google Scholar
• Fonseca JE, Santos MJ, Canhao H, et al. Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev. 2009;8:538–542.
   PubMed Web of Science ®Google Scholar
• Zhou J, Jin JO, Patel ES, et al. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions. Cytokine. 2015;76:244–252.
   PubMed Web of Science ®Google Scholar
• Jin JO, Han X, Yu Q. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun. 2013;40:28–44.
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Brokstad KA, Oijordsbakken G, et al. Salivary glands of primary Sjogren’s syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther. 2011;13:R2.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–558.
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16.
   PubMed Web of Science ®Google Scholar
• Enger TB, Aure MH, Jensen JL, et al. Calcium signaling and cell volume regulation are altered in Sjogren’s syndrome. Acta Odontol Scand. 2014;72:549–556.
   PubMed Web of Science ®Google Scholar
• Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003;19:368–375.
   PubMed Web of Science ®Google Scholar
• Zhao S, Guo Y, Sheng Q, et al. Advanced heat map and clustering analysis using heatmap3. BioMed Res Int. 2014;2014:986048.
   PubMedGoogle Scholar
• Katona K, Farkas N, Suto G, et al. Adipose tissue infiltration in minor salivary glands of patients with Sjögren's syndrome: lack of significant correlation with the disease. An image analysis of 174 cases. Autoimmunity. 2017;50:199–201.
   PubMed Web of Science ®Google Scholar
• Sjostrand M, Ambrosi A, Brauner S, et al. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors. J Immunol. 2013;191:3753–3763.
   PubMed Web of Science ®Google Scholar
• Perez P, Anaya JM, Aguilera S, et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J Autoimmun. 2009;33:99–108.
   PubMed Web of Science ®Google Scholar
• Kimoto O, Sawada J, Shimoyama K, et al. Activation of the interferon pathway in peripheral blood of patients with Sjogren’s syndrome. J Rheumatol. 2011;38:310–316.
   PubMed Web of Science ®Google Scholar
• Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun. 2009;10:285–296.
   PubMed Web of Science ®Google Scholar
• Baechler EC, Batliwalla FM, Reed AM, et al. Gene expression profiling in human autoimmunity. Immunol Rev. 2006;210:120–137.
   PubMed Web of Science ®Google Scholar
• Sjostrand M, Johansson A, Aqrawi L, et al. The expression of BAFF is controlled by IRF transcription factors. J Immunol. 2016;196:91–96.
   PubMed Web of Science ®Google Scholar
• Brkic Z, Maria NI, van Helden-Meeuwsen CG, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren’s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis. 2013;72:728–735.
   PubMed Web of Science ®Google Scholar
• Hulkkonen J, Pertovaara M, Antonen J, et al. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren’s syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford). 2001;40:656–661.
   PubMed Web of Science ®Google Scholar
• Bolstad AI, Jonsson R. Genetic aspects of Sjögren's syndrome. Arthritis Res. 2002;4:353–359.
   PubMedGoogle Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.
   PubMed Web of Science ®Google Scholar
• Szodoray P, Nakken B, Barath S, et al. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders. Hum Immunol. 2013;74:1510–1518.
   PubMed Web of Science ®Google Scholar
• Ohyama Y, Nakamura S, Matsuzaki G, et al. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren’s syndrome. Arthritis Rheum. 1996;39:1376–1384.
   PubMed Web of Science ®Google Scholar
• Nguyen CQ, Yin H, Lee BH, et al. IL17: potential therapeutic target in Sjogren’s syndrome using adenovirus-mediated gene transfer. Lab Investig. 2011;91:54–62.
   PubMed Web of Science ®Google Scholar
• Ogawa N, Ping L, Zhenjun L, et al. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren’s syndrome. Arthritis Rheum. 2002;46:2730–2741.
   PubMed Web of Science ®Google Scholar
• Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293–322.
   PubMed Web of Science ®Google Scholar
• Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651–662.
   PubMed Web of Science ®Google Scholar
• Krause A, Scaletta N, Ji JD, et al. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol. 2002;169:6610–6616.
   PubMed Web of Science ®Google Scholar